Form 4: Korro Bio Director Formela Jean Francois Reports Stock Option Grant

Director Jean Francois Formela of Korro Bio, Inc. reports the acquisition of stock options.

Summary

• On June 11, 2024, Jean Francois Formela, a director of Korro Bio, Inc., reported the acquisition of 5,190 stock options with an exercise price of $42.19.
• The options vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, contingent upon continued service as a non-employee director.
• Formela is obligated to transfer any economic benefit from the sale of shares upon exercise of the option to Atlas Venture Life Science Advisors, LLC, and disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock option grants, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to insider transactions, specifically the granting of stock options to a director, which is a common practice in publicly traded companies to align the interests of directors with those of the shareholders.

Stakeholder Impact

• The granting of stock options to a director can align their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates